Logos Global Management as of Sept. 30, 2022
Portfolio Holdings for Logos Global Management
Logos Global Management holds 38 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 10.9 | $89M | 1.3M | 68.30 | |
| Cytokinetics Com New (CYTK) | 10.1 | $82M | 1.7M | 48.45 | |
| Ideaya Biosciences (IDYA) | 7.6 | $62M | 4.1M | 14.92 | |
| Ventyx Biosciences (VTYX) | 6.0 | $49M | 1.4M | 34.91 | |
| Design Therapeutics (DSGN) | 5.8 | $47M | 2.8M | 16.72 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 5.7 | $47M | 2.0M | 23.26 | |
| Sarepta Therapeutics (SRPT) | 4.8 | $39M | 350k | 110.54 | |
| Allakos (ALLK) | 4.5 | $36M | 5.9M | 6.12 | |
| Karuna Therapeutics Ord | 4.1 | $34M | 150k | 224.93 | |
| Arcutis Biotherapeutics (ARQT) | 3.6 | $29M | 1.5M | 19.11 | |
| Dyne Therapeutics (DYN) | 3.6 | $29M | 2.3M | 12.70 | |
| Alx Oncology Hldgs (ALXO) | 3.5 | $28M | 3.0M | 9.57 | |
| Iveric Bio | 3.3 | $27M | 1.5M | 17.94 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.2 | $26M | 250k | 103.26 | |
| Dice Therapeutics | 2.7 | $22M | 1.1M | 20.28 | |
| Miragen Therapeutics (VRDN) | 2.5 | $21M | 1.0M | 20.51 | |
| Xenon Pharmaceuticals (XENE) | 2.2 | $18M | 500k | 36.10 | |
| Immunocore Hldgs Ads (IMCR) | 2.0 | $16M | 350k | 46.94 | |
| Fulcrum Therapeutics (FULC) | 1.9 | $16M | 2.0M | 8.09 | |
| Akero Therapeutics (AKRO) | 1.7 | $14M | 400k | 34.05 | |
| Tricida | 1.5 | $13M | 1.2M | 10.48 | |
| Ngm Biopharmaceuticals (NGM) | 1.4 | $11M | 850k | 13.08 | |
| Olema Pharmaceuticals (OLMA) | 1.3 | $10M | 3.7M | 2.76 | |
| Altimmune Com New (ALT) | 1.2 | $9.6M | 750k | 12.77 | |
| Bellus Health Com New | 1.0 | $8.4M | 800k | 10.56 | |
| Kezar Life Sciences (KZR) | 1.0 | $8.2M | 950k | 8.61 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.7 | $5.5M | 510k | 10.73 | |
| Geron Corporation (GERN) | 0.6 | $4.7M | 2.0M | 2.34 | |
| Century Therapeutics (IPSC) | 0.6 | $4.6M | 460k | 9.89 | |
| Vigil Neuroscience (VIGL) | 0.2 | $1.9M | 206k | 9.10 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.2 | $1.6M | 400k | 4.02 | |
| Instil Bio | 0.2 | $1.6M | 332k | 4.84 | |
| Spruce Biosciences (SPRB) | 0.2 | $1.4M | 1.0M | 1.37 | |
| Tyra Biosciences (TYRA) | 0.1 | $1.1M | 127k | 8.79 | |
| Lianbio Sponsored Ads (LIANY) | 0.1 | $616k | 308k | 2.00 | |
| Talaris Therapeutics | 0.1 | $521k | 198k | 2.63 | |
| Pyxis Oncology Common Stock (PYXS) | 0.1 | $434k | 220k | 1.97 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $13k | 67k | 0.20 |
